Brief: Kura Oncology Q2 Collaboration Revenue USD 15.288 Million
07/08/2025 21:05
Aug 07 (Reuters) - Kura Oncology Q2 operating expenses USD 87.954 million. Q2 net income USD -66.122 million
- $877.15m
- $371.52m
- $67.48m
Aug 07 (Reuters) - Kura Oncology Q2 operating expenses USD 87.954 million. Q2 net income USD -66.122 million